Nuclear Medicine


U.S. Manufacture of I-131 Renewed after 30 Years
The University of Missouri Research Reactor recently shipped the first batch of Iodine-131 (I-131), a critical radioisotope used for diagnoses and treatment of thyroid cancer and hyperthyroidism. The shipment makes MURR the first U.S. supplier of I-131 since the 1980s, and the only supplier currently in the United States. More...05 Dec 2018


In Other News
Innovative Afterloader System Streamlines Brachytherapy
SRS Detector Array Validates Dosimetric Treatment Plans
Immobilization System Aids Head and Neck Radiotherapy
Protective Agent Dramatically Cuts Post-Radiation Mucositis
Radium-223 Dichloride Should be Used with Caution
Rectal Spacer Reduces Prostate Cancer Radiotherapy Times
Radiation Beam Imaging System Observes RT in Action
Magnetic Lymph Node Detector Eliminates Radioactive Injections
Advanced TomoTherapy Platform Improves RT Workflow
Software Prints Individual Boluses from CT Images
New Radiotherapy Markers Fade into Oblivion
Autofluorescence Imaging Helps Identify Radiation-Resistant Tumors
New RT System Personalizes Cancer Treatment
Post-Treatment PSA Level May Predict RT Outcomes
Remote Tracking Reduces Dehydration Risk in RT Patients
New MRI Technologies Advance Image-Guided Radiotherapy
Anchored Beacon Transponder Guides Lung Cancer Radiotherapy
Higher Radiation Dose Yields No Survival Benefit in Prostate Cancer
Novel PET Imaging Agent Targets Copper Atoms
PET Scan May Help Personalize Cancer Treatment
Oxygen Microbubbles Sensitize Tumors to Radiation Therapy
Oncology Information System Supports Comprehensive Care
Image-Guided RF Treatment Relieves Lower Back Pain
The Nuclear Medicine channel of MedImaging brings the latest in research and clinical radiotherapy, proton therapy, PET-CT, SPECT, SQUID, radiopharmacology, scintillography, trends and safety concerns.